Koninklijke Philips (PHG) to Release Quarterly Earnings on Monday

Koninklijke Philips (NYSE:PHG) will be announcing its earnings results before the market opens on Monday, April 29th.

Koninklijke Philips (NYSE:PHG) last announced its earnings results on Monday, January 29th. The technology company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.03. Koninklijke Philips had a negative net margin of 2.53% and a positive return on equity of 14.17%. The company had revenue of $5.45 billion during the quarter, compared to analyst estimates of $5.47 billion. On average, analysts expect Koninklijke Philips to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Koninklijke Philips Price Performance

PHG opened at $19.98 on Monday. The firm’s 50 day simple moving average is $20.37 and its two-hundred day simple moving average is $20.87. The company has a market capitalization of $18.55 billion, a PE ratio of -35.05, a PEG ratio of 1.03 and a beta of 0.88. Koninklijke Philips has a 1-year low of $17.75 and a 1-year high of $24.27. The company has a current ratio of 1.20, a quick ratio of 0.78 and a debt-to-equity ratio of 0.58.

Institutional Trading of Koninklijke Philips

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Franklin Resources Inc. purchased a new stake in shares of Koninklijke Philips during the first quarter worth about $209,000. Orion Portfolio Solutions LLC bought a new position in Koninklijke Philips in the 4th quarter worth approximately $209,000. Squarepoint Ops LLC purchased a new stake in Koninklijke Philips during the 4th quarter valued at approximately $206,000. Snowden Capital Advisors LLC bought a new stake in shares of Koninklijke Philips during the second quarter valued at approximately $201,000. Finally, IFP Advisors Inc raised its position in shares of Koninklijke Philips by 18.6% during the second quarter. IFP Advisors Inc now owns 9,168 shares of the technology company’s stock valued at $199,000 after buying an additional 1,435 shares during the last quarter. 13.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. StockNews.com upgraded Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research note on Thursday, February 8th. BNP Paribas cut Koninklijke Philips from an “outperform” rating to an “underperform” rating in a research report on Wednesday, February 7th. One analyst has rated the stock with a sell rating, one has issued a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Koninklijke Philips has an average rating of “Moderate Buy” and an average target price of $19.00.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.